ALLOS THERAPEUTICS, INC. and MUNDIPHARMA MEDICAL COMPANY AMENDED AND RESTATED SUPPLY AGREEMENTSupply Agreement • August 9th, 2013 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED SUPPLY AGREEMENT (this “Agreement”), dated this 29th day of May, 2013 (the “Amendment Effective Date”), is by and between Allos Therapeutics, Inc., a Delaware corporation having a place of business at 11080 Circle Point Road, Suite 430, Westminster, Colorado 80020 (“Allos”), and Mundipharma Medical Company, a partnership organized under the laws of Bermuda, having a place of business at 14 Par-la-Ville Road, P.O. Box HM 2332, Hamilton HM JX, Bermuda (“MMCO”).
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ALLOS THERAPEUTICS, INC., a Delaware corporation and MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED, a Bermuda corporationLicense, Development and Commercialization Agreement • August 9th, 2013 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is entered into as of May 29, 2013 (the “Effective Date”) by and between ALLOS THERAPEUTICS, INC., a Delaware corporation having a place of business at 11080 Circle Point Road, Suite 430, Westminster, Colorado 80020, U.S. (“Allos”), and MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED, a Bermuda corporation having a place of business at Mundipharma House, 14 Par-la-Ville Road, P.O. Box HM 2332, Hamilton HM JX, Bermuda (“Mundipharma”). Allos and Mundipharma are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
